Related Content
Search Google Scholar for:
|
Science 303 (5658): 685-689
Copyright © 2004 by the American Association for the Advancement of Science
PEST Domain-Enriched Tyrosine Phosphatase (PEP) Regulation of Effector/Memory T Cells
Kiminori Hasegawa,1
Flavius Martin,1
Guangming Huang,1
Dan Tumas,2
Lauri Diehl,1,2
Andrew C. Chan1*
Abstract:
Protein tyrosine kinases and phosphatases cooperate to regulate normal immune cell function. We examined the role of PEST domainenriched tyrosine phosphatase (PEP) in regulating T cell antigenreceptor function during thymocyte development and peripheral T cell differentiation. Although normal naïve T cell functions were retained in pep-deficient mice, effector/memory T cells demonstrated enhanced activation of Lck. In turn, this resulted in increased expansion and function of the effector/memory T cell pool, which was also associated with spontaneous development of germinal centers and elevated serum antibody levels. These results revealed a central role for PEP in negatively regulating specific aspects of T cell development and function.
1 Department of Immunology, Genentech, Inc., One DNA Way, South San Francisco, CA 94080, USA
2 Department of Pathology, Genentech, Inc., One DNA Way, South San Francisco, CA 94080, USA
* To whom correspondence should be addressed: acc{at}gene.com
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
- PTPN22 Silencing in the NOD Model Indicates the Type 1 Diabetes-Associated Allele Is Not a Loss-of-Function Variant.
- P. Zheng and S. Kissler (2013)
Diabetes
62, 896-904
| Abstract »
| Full Text »
| PDF »
- Lack of the Phosphatase PTPN22 Increases Adhesion of Murine Regulatory T Cells to Improve Their Immunosuppressive Function.
- R. J. Brownlie, L. A. Miosge, D. Vassilakos, L. M. Svensson, A. Cope, and R. Zamoyska (2012)
Science Signaling
5, ra87
| Abstract »
| Full Text »
| PDF »
- Overexpression of the autoimmunity-associated phosphatase PTPN22 promotes survival of antigen-stimulated CLL cells by selectively activating AKT.
- R. Negro, S. Gobessi, P. G. Longo, Y. He, Z.-Y. Zhang, L. Laurenti, and D. G. Efremov (2012)
Blood
119, 6278-6287
| Abstract »
| Full Text »
| PDF »
- PTPN22 Alters the Development of Regulatory T Cells in the Thymus.
- C. J. Maine, E. E. Hamilton-Williams, J. Cheung, S. M. Stanford, N. Bottini, L. S. Wicker, and L. A. Sherman (2012)
J. Immunol.
188, 5267-5275
| Abstract »
| Full Text »
| PDF »
- PTPN22 R620W polymorphism in the ANCA-associated vasculitides.
- D. Martorana, F. Maritati, G. Malerba, F. Bonatti, F. Alberici, E. Oliva, P. Sebastio, L. Manenti, R. Brugnano, M. G. Catanoso, et al. (2012)
Rheumatology
51, 805-812
| Abstract »
| Full Text »
| PDF »
- The association between the PTPN22 C1858T polymorphism and systemic lupus erythematosus: a meta-analysis update.
- W. Lea and Y. Lee (2011)
Lupus
20, 51-57
| Abstract »
| Full Text »
| PDF »
- Autoimmune-associated PTPN22 R620W Variation Reduces Phosphorylation of Lymphoid Phosphatase on an Inhibitory Tyrosine Residue.
- E. Fiorillo, V. Orru, S. M. Stanford, Y. Liu, M. Salek, N. Rapini, A. D. Schenone, P. Saccucci, L. G. Delogu, F. Angelini, et al. (2010)
J. Biol. Chem.
285, 26506-26518
| Abstract »
| Full Text »
| PDF »
- Regulatory polymorphisms in EGR2 are associated with susceptibility to systemic lupus erythematosus.
- K. Myouzen, Y. Kochi, K. Shimane, K. Fujio, T. Okamura, Y. Okada, A. Suzuki, T. Atsumi, S. Ito, K. Takada, et al. (2010)
Hum. Mol. Genet.
19, 2313-2320
| Abstract »
| Full Text »
| PDF »
- The CD8+ memory T-cell state of readiness is actively maintained and reversible.
- A. Allam, D. B. Conze, M. L. Giardino Torchia, I. Munitic, H. Yagita, R. T. Sowell, A. L. Marzo, and J. D. Ashwell (2009)
Blood
114, 2121-2130
| Abstract »
| Full Text »
| PDF »
- PTPN22 Deficiency Cooperates with the CD45 E613R Allele to Break Tolerance on a Non-Autoimmune Background.
- J. Zikherman, M. Hermiston, D. Steiner, K. Hasegawa, A. Chan, and A. Weiss (2009)
J. Immunol.
182, 4093-4106
| Abstract »
| Full Text »
| PDF »
- Structure, inhibitor, and regulatory mechanism of Lyp, a lymphoid-specific tyrosine phosphatase implicated in autoimmune diseases.
- X. Yu, J.-P. Sun, Y. He, X. Guo, S. Liu, B. Zhou, A. Hudmon, and Z.-Y. Zhang (2007)
PNAS
104, 19767-19772
| Abstract »
| Full Text »
| PDF »
- Dual Specificity Phosphatase 1 Knockout Mice Show Enhanced Susceptibility to Anaphylaxis but Are Sensitive to Glucocorticoids.
- J. V. Maier, S. Brema, J. Tuckermann, U. Herzer, M. Klein, M. Stassen, A. Moorthy, and A. C. B. Cato (2007)
Mol. Endocrinol.
21, 2663-2671
| Abstract »
| Full Text »
| PDF »
- Genetic Variation in PTPN22 Corresponds to Altered Function of T and B Lymphocytes.
- M. Rieck, A. Arechiga, S. Onengut-Gumuscu, C. Greenbaum, P. Concannon, and J. H. Buckner (2007)
J. Immunol.
179, 4704-4710
| Abstract »
| Full Text »
| PDF »
- Normal TCR Signal Transduction in Mice That Lack Catalytically Active PTPN3 Protein Tyrosine Phosphatase.
- T. J. Bauler, E. D. Hughes, Y. Arimura, T. Mustelin, T. L. Saunders, and P. D. King (2007)
J. Immunol.
178, 3680-3687
| Abstract »
| Full Text »
| PDF »
- PTPN22 R620W Functional Variant in Type 1 Diabetes and Autoimmunity Related Traits.
- C. Chelala, S. Duchatelet, M.-L. Joffret, R. Bergholdt, D. Dubois-Laforgue, P. Ghandil, F. Pociot, S. Caillat-Zucman, J. Timsit, and C. Julier (2007)
Diabetes
56, 522-526
| Abstract »
| Full Text »
| PDF »
- Differential Clearance and Immune Responses to Tick Cell-Derived versus Macrophage Culture-Derived Ehrlichia chaffeensis in Mice.
- R. R. Ganta, C. Cheng, E. C. Miller, B. L. McGuire, L. Peddireddi, K. R. Sirigireddy, and S. K. Chapes (2007)
Infect. Immun.
75, 135-145
| Abstract »
| Full Text »
| PDF »
- The PTPN22 C1858T functional polymorphism and autoimmune diseases--a meta-analysis.
- Y. H. Lee, Y. H. Rho, S. J. Choi, J. D. Ji, G. G. Song, S. K. Nath, and J. B. Harley (2007)
Rheumatology
46, 49-56
| Abstract »
| Full Text »
| PDF »
- Evidence for a Role for Notch Signaling in the Cytokine-Dependent Survival of Activated T Cells.
- G. Bheeshmachar, D. Purushotaman, H. Sade, V. Gunasekharan, A. Rangarajan, and A. Sarin (2006)
J. Immunol.
177, 5041-5050
| Abstract »
| Full Text »
| PDF »
- A biosynthetic pathway for anandamide.
- J. Liu, L. Wang, J. Harvey-White, D. Osei-Hyiaman, R. Razdan, Q. Gong, A. C. Chan, Z. Zhou, B. X. Huang, H.-Y. Kim, et al. (2006)
PNAS
103, 13345-13350
| Abstract »
| Full Text »
| PDF »
- Evidence for susceptibility determinant(s) to psoriasis vulgaris in or near PTPN22 in German patients.
- U Huffmeier, M Steffens, H Burkhardt, J Lascorz, F Schurmeier-Horst, M Stander, R Kelsch, C Baumann, W Kuster, R Mossner, et al. (2006)
J. Med. Genet.
43, 517-522
| Abstract »
| Full Text »
| PDF »
- CD2BP1 Modulates CD2-Dependent T Cell Activation via Linkage to Protein Tyrosine Phosphatase (PTP)-PEST.
- H. Yang and E. L. Reinherz (2006)
J. Immunol.
176, 5898-5907
| Abstract »
| Full Text »
| PDF »
- Lack of association between ankylosing spondylitis and a functional polymorphism of PTPN22 proposed as a general susceptibility marker for autoimmunity.
- G Orozco, C Garcia-Porrua, M A Lopez-Nevot, E Raya, M A Gonzalez-Gay, and J Martin (2006)
Ann Rheum Dis
65, 687-688
| Full Text »
| PDF »
- Identification of Substrates of Human Protein-tyrosine Phosphatase PTPN22.
- J. Wu, A. Katrekar, L. A. Honigberg, A. M. Smith, M. T. Conn, J. Tang, D. Jeffery, K. Mortara, J. Sampang, S. R. Williams, et al. (2006)
J. Biol. Chem.
281, 11002-11010
| Abstract »
| Full Text »
| PDF »
- The association of PTPN22 with rheumatoid arthritis and juvenile idiopathic arthritis.
- A. Hinks, J. Worthington, and W. Thomson (2006)
Rheumatology
45, 365-368
| Full Text »
| PDF »
- Confirmation of the association of the R620W polymorphism in the protein tyrosine phosphatase PTPN22 with type 1 diabetes in a family based study.
- H Qu, M-C Tessier, T J Hudson, and C Polychronakos (2005)
J. Med. Genet.
42, 266-270
| Full Text »
| PDF »
- Replication of an Association Between the Lymphoid Tyrosine Phosphatase Locus (LYP/PTPN22) With Type 1 Diabetes, and Evidence for Its Role as a General Autoimmunity Locus.
- D. Smyth, J. D. Cooper, J. E. Collins, J. M. Heward, J. A. Franklyn, J. M.M. Howson, A. Vella, S. Nutland, H. E. Rance, L. Maier, et al. (2004)
Diabetes
53, 3020-3023
| Abstract »
| Full Text »
| PDF »
|
|